首頁 > 市場調查報告書 > 醫療設備

生技設備

血漿療法市場規模、佔有率和成長分析（按類型、來源、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1903152

血漿療法市場規模、佔有率和成長分析（按類型、來源、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Plasma Therapy Market Size, Share, and Growth Analysis, By Type (Pure PRP, Leukocyte-Rich PRP), By Source (Autologous, Allogenic), By Application, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球血漿療法市場規模將達到 3.5433 億美元，到 2025 年將成長至 4.05 億美元，到 2033 年將成長至 11.7984 億美元，在預測期（2026-2033 年）內複合年成長率為 14.3%。

受男性型脫髮症和運動傷害發病率上升的推動，全球血漿療法正經歷顯著成長。由於血漿中含有高濃度抗體，其治療用途可將康復者的免疫力轉移給患者，從而拓展了其應用範圍，使其不再局限於整形外科、皮膚科和牙科。整形外科疾病盛行率的不斷上升帶來了更多機遇，而富血小板血漿在各種治療領域的廣泛應用進一步提升了市場潛力。然而，挑戰依然存在，包括報銷指南不一致、成本波動以及在糖尿病和腎臟病患者中的適用性有限，這些都可能阻礙市場擴張。整體而言，隨著不同患者群體需求的持續成長，市場格局正蓄勢待發，即將迎來動態變化。

全球血漿療法市場促進因素

全球血漿療法市場正因運動傷害發生率的上升和美容手術的激增而蓬勃發展。此外，參與各類體育活動的人數不斷增加，進一步推動了對有效治療方法的需求。同時，富血小板血漿（PRP）在研究領域的應用日益廣泛，使人們對其益處和應用領域有了更深入的了解。這些因素共同推動了運動醫學和美容外科領域對創新治療方案的需求，從而促進了整個血漿療法市場的成長和擴張。

限制全球血漿療法市場的因素

全球血漿療法市場成長面臨許多挑戰，主要原因在於該療法的高昂費用。從血液中提取血漿以及後續儲存的成本阻礙了其廣泛應用，並限制了市場潛力。在許多發展中地區，治療費用高昂限制了其普及，導致很大一部分人群無法獲得此類治療。因此，一般民眾無力負擔血漿療法的費用已成為阻礙市場擴張和更廣泛接受度的關鍵因素。

全球血漿療法市場趨勢

全球血漿療法市場呈現顯著上升趨勢，主要受男性型脫髮症和整形外科疾病等疾病日益普遍的推動。對創新治療方案需求的激增凸顯了消費者對血漿療法的接受度不斷提高。然而，對糖尿病和腎臟病患者療效有限等挑戰可能會阻礙其更廣泛的應用。此外，醫療技術的進步不僅使治療方法更加多樣化，也提高了包括罕見疾病在內的多種疾病的治療成功率。公共和私營部門不斷擴大服務範圍，進一步推動了這一成長，使不同收入水平的患者更容易獲得治療。

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較
主要企業簡介
- CSL Behring（澳洲）
- 格里福爾斯公司（西班牙）
- Kedrion SpA（義大利）
- Octapharma AG（瑞士）
- 武田藥品工業株式會社（日本）
- Zimmer Biomet（美國）
- 百特國際有限公司（美國）
- 中國生物製品控股有限公司（中國）
- GC製藥（韓國）
- 韓國綠十字公司
- 日本血液製品機構（日本）
- LFB SA（法國）
- 上海瑞斯血液製品有限公司（中國）
- 中國物聯網集團股份有限公司（CNBG）（中國）
- 廣州白雲山藥業控股有限公司（中國）
- 江西博亞生物製藥有限公司（中國）
- 生物製品實驗室有限公司（BPL）（英國）
- BioLife 血漿服務（美國）
- 加拿大血漿資源公司（加拿大）

結論與建議

簡介目錄

Product Code: SQMIG35H2056

Global Plasma Therapy Market size was valued at USD 354.33 Million in 2024 and is poised to grow from USD 405 Million in 2025 to USD 1179.84 Million by 2033, growing at a CAGR of 14.3% during the forecast period (2026-2033).

Global Plasma Therapy is experiencing considerable growth, driven by the increasing incidence of androgenic alopecia and sports injuries. As plasma contains a high concentration of antibodies, its therapeutic use helps transfer immunity from recovered individuals to patients, with applications expanding beyond orthopaedics, dermatology, and dentistry. The rising prevalence of orthopedic disorders presents additional opportunities, while the widespread adoption of platelet-rich plasma in various therapeutic areas further boosts market potential. However, challenges remain, including inconsistent reimbursement guidelines, varying costs, and limited applicability in diabetic patients and those with kidney issues, which may hinder market expansion. Overall, the landscape is poised for dynamic changes as demand continues to rise across diverse patient demographics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Plasma Therapy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Plasma Therapy Market Segments Analysis

Global Plasma Therapy Market is segmented by Type, Source, Application, End User and region. Based on Type, the market is segmented into Pure PRP, Leukocyte-Rich PRP, Pure Platelet-Rich Fibrin and Leukocyte-Rich Fibrin. Based on Source, the market is segmented into Autologous and Allogenic. Based on Application, the market is segmented into Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. Based on End User, the market is segmented into Hospitals & Clinics and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Plasma Therapy Market

The Global Plasma Therapy market is experiencing growth due to a rising incidence of sports injuries and a surge in cosmetic procedures. Additionally, there is an expanding number of individuals participating in various athletic activities, which further fuels demand for effective treatment options. Moreover, the application of platelet-rich plasma (PRP) in research settings is on the rise, contributing to advancements in understanding its benefits and applications. This combination of factors enhances the need for innovative therapeutic solutions in both sports medicine and cosmetic enhancements, thus driving the overall development and expansion of the plasma therapy market.

Restraints in the Global Plasma Therapy Market

The growth of the global plasma therapy market faces significant challenges primarily due to the high costs associated with the procedure. The expenses incurred in the extraction of plasma from blood and the subsequent storage of this plasma hinder widespread adoption and limit market potential. In many underdeveloped and developing regions, the financial burden of therapy restricts its accessibility, making it difficult for a large segment of the population to utilize these treatments. Consequently, the inability of the average individual to afford plasma therapy emerges as a critical factor obstructing the market's expansion and broader acceptance.

Market Trends of the Global Plasma Therapy Market

The Global Plasma Therapy market is witnessing a significant upward trend driven by the increasing prevalence of conditions like androgenic alopecia and orthopedic disorders. This surge in demand for innovative treatment options highlights the expanding acceptance of plasma therapy among consumers. However, challenges such as limited efficacy in diabetic and kidney disease patients may hinder broader adoption. Moreover, advancements in healthcare technologies have not only diversified treatment options but also improved the success rates across various medical conditions, including rare diseases. This growth is further supported by enhanced service offerings from public and private sectors, fostering accessibility for patients with varying disposable incomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Plasma Therapy Market Size by Type & CAGR (2026-2033)

Market Overview
Pure PRP
Leukocyte-Rich PRP
Pure Platelet-Rich Fibrin
Leukocyte-Rich Fibrin

Global Plasma Therapy Market Size by Source & CAGR (2026-2033)

Market Overview
Autologous
Allogenic

Global Plasma Therapy Market Size by Application & CAGR (2026-2033)

Market Overview
Orthopedic
- Arthritis
- Chronic Tendinitis
- Bone Repair & Regeneration
Dermatology
- Androgenic Alopecia
- Plastic Surgery
Cardiac Muscle Injury
Dental
Nerve Injury
Others

Global Plasma Therapy Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & Clinics
Research Institutes

Global Plasma Therapy Market Size & CAGR (2026-2033)

North America (Type, Source, Application, End User)
- US
- Canada
Europe (Type, Source, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Source, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Source, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Source, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

CSL Behring (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kedrion S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Octapharma AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takeda Pharmaceutical Company Limited (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zimmer Biomet (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China Biologic Products Holdings, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC Pharma (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Green Cross Corp. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Japan Blood Products Organization (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LFB SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai RAAS Blood Products Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
China National Biotec Group Co., Ltd. (CNBG) (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jiangxi Boya Bio-Pharmaceutical Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Products Laboratory Ltd. (BPL) (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioLife Plasma Services (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Canadian Plasma Resources (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments